ID

22010

Descripción

Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00316199

Link

https://clinicaltrials.gov/show/NCT00316199

Palabras clave

Versiones (1)
  1. 14/5/17 14/5/17 -
Subido en

14 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Metastatic Breast Cancer NCT00316199

Inglés

Eligibility Metastatic Breast Cancer NCT00316199

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients of chinese origin with histologically or cytologically proven diagnosis of breast cancer.
Descripción

breast cancer, gender, chinese origin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0152035
unresectable, locally recurrent breast cancer or stage iv disease.
Descripción

breast cancer stage, unresectable, locally recurrent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0027646
UMLS CUI [1,3]
C1519810
UMLS CUI [1,4]
C2986682
have at least one measurable lesion as defined by response evaluation criteria in solid tumors (recist) criteria.
Descripción

response evaluation criteria in solid tumors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1709926
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
Descripción

ecog

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
treatment with an anthracycline-based chemotherapy regimen in the adjuvant/neoadjuvant setting with subsequent disease relapse.
Descripción

anthracycline-base chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0282564
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy for unresectable, locally advanced breast cancer or metastatic disease.
Descripción

breast cancer, unresectable, locally advanced, metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C1519810
UMLS CUI [1,4]
C0677984
UMLS CUI [1,5]
C0027627
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy, and immunotherapy.
Descripción

concurrent tumor therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
known or suspected brain metastasis or second primary malignancy that is clinically detectable at the time of consideration for study enrollment.
Descripción

brain metastasis, second primary malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0751623
active infection or other serious condition.
Descripción

infection, comorbidities

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0009488
pregnant or breastfeeding.
Descripción

pregnancy, breast feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Metastatic Breast Cancer NCT00316199

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
breast cancer, gender, chinese origin
Item
female patients of chinese origin with histologically or cytologically proven diagnosis of breast cancer.
boolean
C0678222 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0152035 (UMLS CUI [3])
breast cancer stage, unresectable, locally recurrent
Item
unresectable, locally recurrent breast cancer or stage iv disease.
boolean
C0678222 (UMLS CUI [1,1])
C0027646 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,3])
C2986682 (UMLS CUI [1,4])
response evaluation criteria in solid tumors
Item
have at least one measurable lesion as defined by response evaluation criteria in solid tumors (recist) criteria.
boolean
C1709926 (UMLS CUI [1])
ecog
Item
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
boolean
C1520224 (UMLS CUI [1])
anthracycline-base chemotherapy
Item
treatment with an anthracycline-based chemotherapy regimen in the adjuvant/neoadjuvant setting with subsequent disease relapse.
boolean
C0392920 (UMLS CUI [1,1])
C0282564 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
breast cancer, unresectable, locally advanced, metastatic
Item
prior chemotherapy for unresectable, locally advanced breast cancer or metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,3])
C0677984 (UMLS CUI [1,4])
C0027627 (UMLS CUI [1,5])
concurrent tumor therapy
Item
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy, and immunotherapy.
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
brain metastasis, second primary malignancy
Item
known or suspected brain metastasis or second primary malignancy that is clinically detectable at the time of consideration for study enrollment.
boolean
C0220650 (UMLS CUI [1])
C0751623 (UMLS CUI [2])
infection, comorbidities
Item
active infection or other serious condition.
boolean
C0009450 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
pregnancy, breast feeding
Item
pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial